Detailed Information on Publication Record
2016
High frequency of Candida fabianii among clinical isolates biochemically identified as Candida pelliculosa and Candida utilis
SVOBODOVA, L., D. BEDNAROVA, Filip RŮŽIČKA, V. CHRENKOVÁ, R. DOBIAS et. al.Basic information
Original name
High frequency of Candida fabianii among clinical isolates biochemically identified as Candida pelliculosa and Candida utilis
Authors
SVOBODOVA, L. (203 Czech Republic), D. BEDNAROVA (203 Czech Republic), Filip RŮŽIČKA (203 Czech Republic, guarantor, belonging to the institution), V. CHRENKOVÁ (203 Czech Republic), R. DOBIAS (203 Czech Republic), N. MALLATOVA (203 Czech Republic), V. BUCHTA (203 Czech Republic), Iva KOCMANOVÁ (203 Czech Republic), P. OLISAROVA (203 Czech Republic), N. STROMEROVA (203 Czech Republic), Y. THONGSRI (764 Thailand) and P. HAMAL (203 Czech Republic)
Edition
Mycoses, Hoboken, Wiley-Blackwell, 2016, 0933-7407
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10600 1.6 Biological sciences
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 2.252
RIV identification code
RIV/00216224:14110/16:00090598
Organization unit
Faculty of Medicine
UT WoS
000372295900005
Keywords in English
Candida fabianii; MALDI-TOF MS; biochemical identification; antifungal susceptibility testing
Tags
Tags
International impact, Reviewed
Změněno: 9/11/2016 15:10, Ing. Mgr. Věra Pospíšilíková
Abstract
V originále
Clinical yeast isolates belonging to Candida pelliculosa, Candida utilis and Candida fabianii are difficult to distinguish in a routine mycology laboratory using common biochemical tests. The aims of this study were to determine the prevalence of C. pelliculosa, C. utilis and C. fabianii in clinical samples and to compare their minimum inhibitory concentrations (MICs) to systemic antifungals. Two hundred and forty-eight clinical yeast isolates obtained from eight large hospitals in the Czech Republic were included in this study. Identification was performed biochemically using ID 32C kit and by MALDI-TOF MS. MICs were determined using colorimetric broth dilution Sensititre YeastOne panels. From a total number of 248 isolates, 175 were identified as C. pelliculosa and 73 as C. utilis using the biochemical kit. In contrast, MALDI-TOF MS identified 222 isolates as C. fabianii, 20 as C. pelliculosa and 6 as C. utilis. The highest mean MICs were found in C. fabianii and, regardless of the studied species, in isolates from blood cultures and central venous catheters. MALDI-TOF MS revealed C. fabianii to be most prevalent in clinical samples as compared with the other studied species. Higher MIC values in C. fabianii support the importance of correct identification of this species.